West Pharmaceutical Services | WST - Net Income



West Pharmaceutical Services reported $131.8M in Net Income for its fiscal quarter ending in June of 2025.


Net Income Change Date
Align Technology USD 124.61M 31.38M Jun/2025
Avanos Medical USD -76800000 83.4M Jun/2025
Baxter International USD 91M 35M Jun/2025
Becton, Dickinson and Co. USD 574M 266M Jun/2025
Charles River Laboratories USD 52.33M 26.86M Jun/2025
Cooper Companies USD 98.3M 10.6M Jul/2025
Dentsply International USD -45000000 65M Jun/2025
Haemonetics USD 34.03M 23.95M Jun/2025
ICU Medical USD 35.34M 50.81M Jun/2025
Insulet USD 22.5M 12.9M Jun/2025
Integra LifeSciences USD -484073000 458.78M Jun/2025
IQVIA Holdings USD 266M 17M Jun/2025
J&J USD 5.54B 5.46B Jun/2025
Medtronic USD 1.04B 17M Jul/2025
Merit Medical Systems USD 32.58M 2.43M Jun/2025
Neogen USD -612196000 601.24M May/2025
Quidel USD -255400000 242.7M Jun/2025
Repligen USD 14.87M 9.04M Jun/2025
Solventum Corp 90M 47M Jun/2025
STAAR Surgical USD -16812000 37.4M Jun/2025
Terumo JPY 41.84B 23.49B Jun/2025
West Pharmaceutical Services USD 131.8M 42M Jun/2025